One Interface. Faster Patient Enrollment. FDA-Ready Data.
At JRC, we provide global innovative biotech companies with a single accountable interface for conducting clinical trials in China. By integrating China’s top CRO/SMO partners with our exclusive physician and hospital network, we deliver rapid enrollment and FDA-compliant data packages that can be seamlessly integrated into regulatory packages for global approvals.
Our model is designed for speed and reliability: site and regulatory setup within 60 days, followed by first patient enrollment within the next 60 days. With AI-enabled patient screening and remote monitoring, we ensure both efficiency and data quality.
Solutions
Solution #1 – JRC Cross-Border Clinical Trial Solution